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over a new leaf. Until now, Immunity has been edited
by academic scientists. However, from mid-December
2005 all new manuscripts submitted to Immunity will
be handled by a team of professional editors based at
Cell Press in Cambridge, Massachusetts.
Since its inception in 1994, Immunity has been a forum
for groundbreaking immunology research. This success
was largely due to the exceptional acumen of numerous
distinguished scientists who served as editors. The
journal was nurtured at Harvard University and the Mas-
sachusetts Institute of Technology followed by Wash-
ington University, Yale University, and now the National
Institutes of Health. The academic editors at these insti-
tutions skillfully combined full-time research careers
with the substantial demands of selecting the best work
in the field for publication. With the ‘‘maturation’’ of
Immunity as a scientific journal, and with changes in
the research and publishing environment, it has become
apparent that the progress of the journal will require
a considerably greater time commitment than in previ-
ous years, far more than could reasonably be asked
of academic editors. After extensive consultation with
members of the immunology community, Cell Press de-
cided that a dedicated staff of full-time editors would
serve the journal and the community most effectively
from this point onwards.
The move to an ‘‘in-house’’ editorial model will enable
Immunity to take advantage of the resources within the
Cell Press office, where ten other Cell Press journals are
housed. Although the journals are editorially indepen-
dent, the collective experience of all the editors is an in-
valuable asset in providing the best service to authors,
reviewers and readers. As an example of this synergy,
Immunity (representing Cell Press) will be sponsoring
the Boston Area Immunology meeting on December 9
at the Tufts University School of Medicine. This spon-
sorship is part of our commitment to actively participate
in and be accessible to the community. Please see the
announcement of the meeting in this issue and the Im-
munity homepage for more details.
On behalf of Cell Press, I sincerely thank the out-
going editors, B.J. Fowlkes, Ronald Germain, Warren
Leonard, William Paul, and Lawrence Samelson, who
were outstanding in steering the journal in the past three
years. These editors will relinquish their position at the
journal by the end of January 2006. It is a testament totheir dedication that despite their numerous responsi-
bilities, they have devoted a tremendous amount of their
time to ensuring the journal continues to publish the
most innovative and perceptive work in the field.
The new editorial team comprises myself, Peter Lee,
previously a senior editor at Nature Immunology, and
Julie Stacey, who has been an editor at Cell Press since
mid-2004 and who has substantial experience in editing
Immunity, Molecular Cell, and Cell. My research back-
ground includes infectious disease, asthma and allergy,
and autoimmune disease, whereas Julie’s scientific
training was in molecular virology and viral immunology.
Julie and I will be traveling to numerous scientific meet-
ings, including the Keystone symposia on host-patho-
gen interaction (Keystone, January 6) and viral immunity
(Steamboat, March 28). If you see us, please introduce
yourself; we would be delighted to discuss your work
and to hear any feedback you have about the journal
and the changes taking place.
As always, Immunity welcomes manuscripts from all
aspects of immunology research, including those that
provide molecular and cellular insights as well as in vivo
studies of the immune system. Any area of investigation
that substantially advances our understanding of the
immune system is appropriate for consideration at
Immunity. We therefore encourage the submission of
work in all relevant areas to ensure Immunity is a forum
for the most important advances across the broadest
scope of immunology.
Time is, of course, of the essence in this day and age.
We will strive to inform authors within two to three work-
ing days if a submitted manuscript does not meet the
criteria for in-depth review. For those manuscripts pro-
ceeding to external review, we will aim to secure appro-
priate referees quickly and to make an editorial decision
within two days of receiving reviewers’ comments. On
occasion, manuscripts may take longer to process than
expected, but you should beassured that such cases are
likely a result of further careful discussion and consulta-
tion by the editors. We will always strive to be helpful,
thoughtful, and fair throughout the course of the review.
In the new year, you will continue to see exciting
changes to the journal in terms of its content. We hope
you will enjoy the ‘‘new and improved’’ Immunity, and
we wish you every success for the coming year.
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